MRCM
MRNA icon

M&R Capital Management’s Moderna MRNA Stock Holding History

M&R Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13.4K Hold
200
– – ﹤0.01% 360
2024
Q2 		$23.8K Hold
200
– – 0.01% 281
2024
Q1 		$22.1K Hold
200
– – 0.01% 289
2023
Q4 		$19.9K Buy
+200
New +$16.8K 0.01% 323

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

M&R Capital Management's MRNA Position: Q3 2024 in Review

M&R Capital Management held its Moderna (MRNA) position steady in Q3 2024 at 200 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #360.

M&R Capital Management first reported a position in MRNA in Q4 2023 and has held it in 4 quarters since. The position peaked at $23.8K in Q2 2024. 789 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • M&R Capital Management held 200 shares of Moderna worth $13.4K as of Q3 2024.
  • M&R Capital Management left its Moderna share count unchanged in Q3 2024.
  • Moderna made up ﹤0.01% of M&R Capital Management's portfolio in Q3 2024, its #360 holding.
  • M&R Capital Management first reported a position in Moderna in Q4 2023 and has held it in 4 quarters since.
  • M&R Capital Management's Moderna position peaked at $23.8K in Q2 2024.
  • 789 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on M&R Capital Management's 13F filing for Q3 2024, filed 2 Oct 2024.